153 related articles for article (PubMed ID: 23162614)
1. DBC1 does not function as a negative regulator of SIRT1 in liver cancer.
Bae HJ; Chang YG; Noh JH; Kim JK; Eun JW; Jung KH; Kim MG; Shen Q; Ahn YM; Kwon SH; Park WS; Lee JY; Nam SW
Oncol Lett; 2012 Nov; 4(5):873-877. PubMed ID: 23162614
[TBL] [Abstract][Full Text] [Related]
2. Expression of DBC1 is associated with nuclear grade and HER2 expression in breast cancer.
Hiraike H; Wada-Hiraike O; Nakagawa S; Saji S; Maeda D; Miyamoto Y; Sone K; Tanikawa M; Oda K; Nakagawa K; Yano T; Fukayama M; Taketani Y
Exp Ther Med; 2011 Nov; 2(6):1105-1109. PubMed ID: 22977628
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer metastasis suppressor 1 modulates SIRT1-dependent p53 deacetylation through interacting with DBC1.
Liu X; Ehmed E; Li B; Dou J; Qiao X; Jiang W; Yang X; Qiao S; Wu Y
Am J Cancer Res; 2016; 6(6):1441-9. PubMed ID: 27429856
[TBL] [Abstract][Full Text] [Related]
4. Deleted in breast cancer-1 regulates SIRT1 activity and contributes to high-fat diet-induced liver steatosis in mice.
Escande C; Chini CC; Nin V; Dykhouse KM; Novak CM; Levine J; van Deursen J; Gores GJ; Chen J; Lou Z; Chini EN
J Clin Invest; 2010 Feb; 120(2):545-58. PubMed ID: 20071779
[TBL] [Abstract][Full Text] [Related]
5. Role of deleted in breast cancer 1 (DBC1) protein in SIRT1 deacetylase activation induced by protein kinase A and AMP-activated protein kinase.
Nin V; Escande C; Chini CC; Giri S; Camacho-Pereira J; Matalonga J; Lou Z; Chini EN
J Biol Chem; 2012 Jul; 287(28):23489-501. PubMed ID: 22553202
[TBL] [Abstract][Full Text] [Related]
6. Negative regulation of the deacetylase SIRT1 by DBC1.
Zhao W; Kruse JP; Tang Y; Jung SY; Qin J; Gu W
Nature; 2008 Jan; 451(7178):587-90. PubMed ID: 18235502
[TBL] [Abstract][Full Text] [Related]
7. A novel form of Deleted in breast cancer 1 (DBC1) lacking the N-terminal domain does not bind SIRT1 and is dynamically regulated in vivo.
Santos L; Colman L; Contreras P; Chini CC; Carlomagno A; Leyva A; Bresque M; Marmisolle I; Quijano C; Durán R; Irigoín F; Prieto-Echagüe V; Vendelbo MH; Sotelo-Silveira JR; Chini EN; Badano JL; Calliari AJ; Escande C
Sci Rep; 2019 Oct; 9(1):14381. PubMed ID: 31591441
[TBL] [Abstract][Full Text] [Related]
8. DBC1 phosphorylation by ATM/ATR inhibits SIRT1 deacetylase in response to DNA damage.
Zannini L; Buscemi G; Kim JE; Fontanella E; Delia D
J Mol Cell Biol; 2012 Oct; 4(5):294-303. PubMed ID: 22735644
[TBL] [Abstract][Full Text] [Related]
9. Balance between SIRT1 and DBC1 expression is lost in breast cancer.
Sung JY; Kim R; Kim JE; Lee J
Cancer Sci; 2010 Jul; 101(7):1738-44. PubMed ID: 20412117
[TBL] [Abstract][Full Text] [Related]
10. Expression of DBC1 and SIRT1 is associated with poor prognosis of gastric carcinoma.
Cha EJ; Noh SJ; Kwon KS; Kim CY; Park BH; Park HS; Lee H; Chung MJ; Kang MJ; Lee DG; Moon WS; Jang KY
Clin Cancer Res; 2009 Jul; 15(13):4453-9. PubMed ID: 19509139
[TBL] [Abstract][Full Text] [Related]
11. DBC1 functions as a tumor suppressor by regulating p53 stability.
Qin B; Minter-Dykhouse K; Yu J; Zhang J; Liu T; Zhang H; Lee S; Kim J; Wang L; Lou Z
Cell Rep; 2015 Mar; 10(8):1324-34. PubMed ID: 25732823
[TBL] [Abstract][Full Text] [Related]
12. SIRT1 Expression Is Associated with Good Prognosis in Colorectal Cancer.
Jung W; Hong KD; Jung WY; Lee E; Shin BK; Kim HK; Kim A; Kim BH
Korean J Pathol; 2013 Aug; 47(4):332-9. PubMed ID: 24009628
[TBL] [Abstract][Full Text] [Related]
13. Reciprocal roles of DBC1 and SIRT1 in regulating estrogen receptor α activity and co-activator synergy.
Yu EJ; Kim SH; Heo K; Ou CY; Stallcup MR; Kim JH
Nucleic Acids Res; 2011 Sep; 39(16):6932-43. PubMed ID: 21596782
[TBL] [Abstract][Full Text] [Related]
14. Acetylation status of P53 and the expression of DBC1, SIRT1, and androgen receptor are associated with survival in clear cell renal cell carcinoma patients.
Noh SJ; Kang MJ; Kim KM; Bae JS; Park HS; Moon WS; Chung MJ; Lee H; Lee DG; Jang KY
Pathology; 2013 Oct; 45(6):574-80. PubMed ID: 24018803
[TBL] [Abstract][Full Text] [Related]
15. Expression of SIRT1 and DBC1 in Gastric Adenocarcinoma.
Kang Y; Jung WY; Lee H; Lee E; Kim A; Kim BH
Korean J Pathol; 2012 Dec; 46(6):523-31. PubMed ID: 23323102
[TBL] [Abstract][Full Text] [Related]
16. DBC1 is a negative regulator of SIRT1.
Kim JE; Chen J; Lou Z
Nature; 2008 Jan; 451(7178):583-6. PubMed ID: 18235501
[TBL] [Abstract][Full Text] [Related]
17. Expression of DBC1 and SIRT1 is associated with poor prognosis for breast carcinoma.
Lee H; Kim KR; Noh SJ; Park HS; Kwon KS; Park BH; Jung SH; Youn HJ; Lee BK; Chung MJ; Koh DH; Moon WS; Jang KY
Hum Pathol; 2011 Feb; 42(2):204-13. PubMed ID: 21056897
[TBL] [Abstract][Full Text] [Related]
18. A positive role of DBC1 in PEA3-mediated progression of estrogen receptor-negative breast cancer.
Kim HJ; Kim SH; Yu EJ; Seo WY; Kim JH
Oncogene; 2015 Aug; 34(34):4500-8. PubMed ID: 25417701
[TBL] [Abstract][Full Text] [Related]
19. Identification of DBC1 as a transcriptional repressor for BRCA1.
Hiraike H; Wada-Hiraike O; Nakagawa S; Koyama S; Miyamoto Y; Sone K; Tanikawa M; Tsuruga T; Nagasaka K; Matsumoto Y; Oda K; Shoji K; Fukuhara H; Saji S; Nakagawa K; Kato S; Yano T; Taketani Y
Br J Cancer; 2010 Mar; 102(6):1061-7. PubMed ID: 20160719
[TBL] [Abstract][Full Text] [Related]
20. SIRT1 phosphorylation by AMP-activated protein kinase regulates p53 acetylation.
Lau AW; Liu P; Inuzuka H; Gao D
Am J Cancer Res; 2014; 4(3):245-55. PubMed ID: 24959379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
